Solara Active Pharma Sciences Limited - Company Profile

It is a pharma public limited company based in Thane, Maharashtra, India, established in 2017.

2017 Thane, Maharashtra, India Active

Last Updated: December 22, 2025

About Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited, a active public limited company, was established on 23 February 2017 in Thane, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24230MH2017PLC291636. Registered under ROC Roc Mumbai. it is listed on BSE: 541540 and NSE: SOLARA. It has an authorized capital of ₹120.00 Cr and a paid-up capital of ₹44.49 Cr.

Formerly known as Ssl Pharma Sciences Limited. It upholds a compliant status. In 2023, it reported revenue of ₹1,465.95 Cr and a net worth of ₹1,503.13 Cr. Employing 1,656 professional, Its leadership includes Rajiv Vijay Nabar (Director), Ramakrishnan Rajagopal (Director), Mohan Muthunarayanan (Whole-Time Director). Past directors included Poorvank Purohit, Bharath Ramraman Sesha, S.Hariharan. It holds ₹1,799.40 Cr open charges and ₹2,310.69 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at Cyber One, Unit No. 902, Sector 30A, Plot No. 4 & 6, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

Company Details

CIN/LLPIN
L24230MH2017PLC291636
Registration Number
291636
Incorporation Date
23 February 2017
Authorized Capital
₹120.00 Cr
Paid-Up Capital
₹44.49 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 541540, NSE: SOLARA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 120.00 Cr as on 22-12-2025
Paid Up Capital ₹ 44.49 Cr as on 22-12-2025
Company Age 8 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 1,799.40 Cr as on 22-12-2025
Satisfied Charges ₹ 2,310.69 Cr as on 22-12-2025
Revenue Growth **** 13.90% (FY 2023)
Profit Growth **** 62.07% (FY 2023)
Ebitda **** 66.82% (FY 2023)
Net Worth -1.57% (FY 2023)
Total Assets -1.86% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Solara Active Pharma Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Solara Active Pharma Sciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rajiv Vijay Nabar	Director	14 Nov 2023	Current
Ramakrishnan Rajagopal	Director	11 Apr 2018	Current
Mohan Muthunarayanan	Whole-Time Director	14 Feb 2024	Current
Manish Gupta	Director	22 Jul 2024	Current
Rajendra Kumar Srivastava	Director	14 Nov 2023	Current
Kausalya Santhanam	Director	11 Apr 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Managing Director	21 Feb 2025	Past
Pramod Abcsdd	Ceo(Kmp)	-	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Director	05 Aug 2023	Past
Pramod Abcsdd	Additional Director	28 Nov 2023	Past
Pramod Abcsdd	Whole-Time Director	24 Aug 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Solara Active Pharma Sciences.

Solara Active Pharma Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.9% increase. The company also saw a substantial improvement in profitability, with a 62.07% increase in profit. The company's net worth dipped by a decrease of 1.57%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

13.90%

*******

Revenue from Operations

*******

13.83%

*******

Total Assets

*******

-1.86%

*******

Profit or Loss

*******

62.07%

*******

Net Worth

*******

-1.57%

*******

EBITDA

*******

66.82%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Solara Active Pharma Sciences?

In 2023, Solara Active Pharma Sciences had a promoter holding of 40.98% and a public holding of 59.01%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹17,994,000,000.00

Satisfied Charges

₹23,106,900,000.00

Charges Breakdown by Lending Institutions

Others : 1659.40 Cr
Yes Bank Limited : 140.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Jan 2025	Others	₹75.00 Cr	Open
28 Sep 2022	Yes Bank Limited	₹65.00 Cr	Open
28 Sep 2022	Yes Bank Limited	₹75.00 Cr	Open
22 Nov 2021	Others	₹150.00 Cr	Open
21 Jan 2021	Others	₹170.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Solara Active Pharma Sciences?

Solara Active Pharma Sciences has a workforce of 1656 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Solara Active Pharma Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solara Active Pharma Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Solara Active Pharma Sciences

Recent Activity within the Organization

Annual General Meeting

The activity Solara Active Pharma Sciences Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.
25 Sep 2025
Director Appointment

The activity Pooja Jaya Kumar was appointed as a Company Secretary was appointed as a Company Secretary on 02 Jun 2025 & has been associated with this company since 8 months 7 days . was completed.
02 Jun 2025
Director Appointment

Progress on Sandeep Shashikantha Rao was appointed as a Ceo was appointed as a Ceo on 02 Apr 2025 & has been associated with this company since 10 months 7 days . was documented.
02 Apr 2025
Director Appointment

Sarat Kumar Asuri was appointed as a Cfo was appointed as a Cfo on 02 Apr 2025 & has been associated with this company since 10 months 7 days . was recorded as a recent event.
02 Apr 2025
Balance Sheet

Progress on Solara Active Pharma Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Director Appointment

Sandeep Shashikantha Rao was appointed as a CEO was appointed as a CEO on 21 Feb 2025 & has been associated with this company since 11 months 17 days . was recorded as a recent event.
21 Feb 2025

Explore recent activity and updates - View Recent Activity